Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

Autor: Visseren, F. L. J., Mach, F., Smulders, Y. M., Carballo, D., Koskinas, K. C., Back, M., Benetos, A., Biffi, A., Boavida, J. -M., Capodanno, D., Cosyns, B., Crawford, C., Davos, C. H., Desormais, I., DI Angelantonio, E., Franco, O. H., Halvorsen, S., Hobbs, F. D. R., Hollander, M., Jankowska, E. A., Michal, M., Sacco, S., Sattar, N., Tokgozoglu, L., Tonstad, S., Tsioufis, K. P., Van DIs, I., Van Gelder, I. C., Wanner, C., Williams, B., De Backer, G., Regitz-Zagrosek, V., Aamodt, A. H., Abdelhamid, M., Aboyans, V., Albus, C., Asteggiano, R., Borger, M. A., Brotons, C., Ielutkiene, J., Cifkova, R., Cikes, M., Cosentino, F., Dagres, N., De Backer, T., De Bacquer, D., Delgado, V., Den Ruijter, H., Dendale, P., Drexel, H., Falk, V., Fauchier, L., Ference, B. A., Ferrieres, J., Ferrini, M., Fisher, M., Fliser, D., Fras, Z., Gaita, D., Giampaoli, S., Gielen, S., Graham, I., Jennings, C., Jorgensen, T., Kautzky-Willer, A., Kavousi, M., Koenig, W., Konradi, A., Kotecha, D., Landmesser, U., Lettino, M., Lewis, B. S., Linhart, A., Lochen, M. -L., Makrilakis, K., Mancia, G., Marques-Vidal, P., Mcevoy, J. W., Mcgreavy, P., Merkely, B., Neubeck, L., Nielsen, J. C., Perk, J., Petersen, S. E., Petronio, A. S., Piepoli, M., Pogosova, N. G., Prescott, E. I. B., Ray, K. K., Reiner, Z., Richter, D. J., Ryden, L., Shlyakhto, E., Sitges, M., Sousa-Uva, M., Sudano, I., Tiberi, M., Touyz, R. M., Ungar, A., Verschuren, W. M. M., Wiklund, O., Wood, D., Zamorano, J. L., Crawford, C. A., Franco Duran, O. H., Richard Hobbs, F. D., Dis, I. V.

Publikováno v: ESC Scientific Document Group 2022, ' 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice ', European Journal of Preventive Cardiology, vol. 29, no. 1, pp. 5-115 . https://doi.org/10.1093/eurjpc/zwab154

These are the clinical practice guidelines from the European Society of Cardiology on cardiovascular disease prevention in clinical practice, from 2021.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f60599ebe75f1e84cacecafbd5cd77e6
http://hdl.handle.net/11697/188995

The natural product Oleuropein shows enhanced anticancer and cardioprotective activity when co-administered in vivo with Doxorubicin

Autor: Papachristodoulou, A. Komianos, K. Psarras, N. Efentakis, P. and Varela, E. Davos, C. Benaki, D. Skaltsounis, L. A. and Andreadou, I Mikros, E. Tsitsilonis, O.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::850d3261003ab856542219265a35aa61
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3187998

Chronic administration of Empagliflozin induces cardioprotection in vivo in absence of diabetes mellitus

Autor: Abu Qourah, F, Nikolaou, Pe, Femmino, S, Tsoumani, M, Varela, A, Davos, C, Dimitriou, C, Kanaki, Z, Dimitriadis, G, Brizzi, Mf, Iliodromitis, Ek, Andreadou, I

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______970::a1bfb6066f9939aca722c311fa161425
http://hdl.handle.net/2318/1726407

Ergophysiological evaluation of heart failure patients with reduced ejection fraction undergoing exercise-based cardiac rehabilitation: a systematic review and meta-analysis

Autor: Christou, G, Christou, M, Davos, C, Markozannes, G, Christou, K, Mantzoukas, S, Christodoulou, D, Kiortsis, D, Christou, P, Tigas, S, Nikoletou, D

Publikováno v: European Journal of Preventive Cardiology; June 2024, Vol. 31 Issue: 1, Number 1 Supplement 1